Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Micrus' slashed earnings forecast stirs discontent among shareholders:

This article was originally published in Clinica

Executive Summary

Disgruntled investors in embolic coil device manufacturer Micrus are suing the company for securities fraud - a reaction to the profit warning issued by the company last month. The San Jose, California firm had cut its revenue guidance for fiscal 2008 as a result of uncertainty over the approvals of products by Chinese and Japanese authorities, as well as slower-than expected sales in North America (see Clinica No 1274, p 3). Schatz Nobel Izard (Hartford, Connecticut) and Couglin Stoia Geller Rudman & Robbins (New York) have filed class action lawsuits in a US district court in Florida on behalf of investors who purchased shares in Micrus between February 12 and September 17 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel